Litigation Details for TEVA PHARMACEUTICALS USA, INC. v. SYNTHON PHARMACEUTICALS, INC. (M.D.N.C. 2014)
✉ Email this page to a colleague
TEVA PHARMACEUTICALS USA, INC. v. SYNTHON PHARMACEUTICALS, INC. (M.D.N.C. 2014)
| Docket | ⤷ Sign Up | Date Filed | 2014-11-19 |
| Court | District Court, M.D. North Carolina | Date Terminated | 2015-02-12 |
| Cause | 35:271 Patent Infringement | Assigned To | Loretta Copeland Biggs |
| Jury Demand | None | Referred To | Joe L. Webster |
| Patents | 8,232,250; 8,399,413 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in TEVA PHARMACEUTICALS USA, INC. v. SYNTHON PHARMACEUTICALS, INC.
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for TEVA PHARMACEUTICALS USA, INC. v. SYNTHON PHARMACEUTICALS, INC. (M.D.N.C. 2014)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2014-11-18 | 1 | of United States Patent No. 8,232,250 (“the ’250 patent”) and United States Patent No. 8,399,413 (“the… COUNT I FOR INFRINGEMENT OF U.S. PATENT NO. 8,232,250 BY DEFENDANTS …DECLARATORY JUDGMENT OF INFRINGMENT OF U.S. PATENT NO. 8,232,250 BY DEFENDANTS 91. The allegations… the ’250 patent is attached as Exhibit A. The ’413 Patent 60. The ’413 patent, entitled … BACKGROUND The ’250 Patent 54. The ’250 patent, entitled “Low Frequency Glatiramer | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
